Feasibility of Preoperative Lymphoscintigraphy for Identification of Sentinel Lymph Nodes in Patients With Conjunctival and Periocular Skin Malignancies
- 1 March 2003
- journal article
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 19 (2) , 102-106
- https://doi.org/10.1097/01.iop.0000056146.62409.24
Abstract
To determine the feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes (SLNs) in patients with conjunctival and periocular skin tumors and to determine the patterns of lymphatic drainage from such tumors.We retrospectively reviewed the records of all patients with biopsy-confirmed conjunctival and periocular skin malignancies who underwent lymphoscintigraphy with or without SLN biopsy between January 1999 and June 2000. Patients underwent lymphoscintigraphy with 0.3 to 1 mCi of technetium Tc-99m sulfur colloid in a volume of either 0.2 mL or 1 mL. Images were taken as soon as the first SLNs were detected through the camera and every 15 minutes thereafter. Intraoperative mapping and SLN biopsy was performed 1 to 2 days after lymphoscintigraphy unless the patient refused or there were medical contraindications to the procedure.The study included 7 patients with malignant melanoma of the conjunctiva or periocular skin and 1 patient with Merkel cell carcinoma of the eyelid. On lymphoscintigraphy, at least 1 SLN was identified in 7 of the 8 patients. Although all lesions located in the lateral half of the ocular adnexa drained to at least one SLN in the parotid (preauricular) area, there was some variability in the drainage patterns of lesions located in the medial half of the ocular adnexa. A smaller injection volume (0.2 mL) was adequate for detecting the nodes draining the area of injection and led to less spread of technetium to the surrounding areas. Six patients underwent SLN biopsy. In all but one, the nodes identified during surgery corresponded with those visualized on lymphoscintigraphy.Preoperative lymphoscintigraphy successfully identifies SLNs in most patients with conjunctival and periocular skin malignancies. Smaller injection volumes (0.2 mL) appear to be adequate for identification of the sentinel nodes and lead to less spread to surrounding tissues.Keywords
This publication has 15 references indexed in Scilit:
- Advances in the Management of Malignant Tumors of the Eyelid and Conjunctiva: The Role of Sentinel Lymph Node BiopsyInternational Ophthalmology Clinics, 2002
- Sentinel Lymph Node Biopsy for Conjunctival MelanomaOphthalmic Plastic & Reconstructive Surgery, 2001
- Sentinel Node Biopsy for Orbital and Ocular Adnexal TumorsOphthalmic Plastic & Reconstructive Surgery, 2001
- Sentinel Lymph Node Mapping for Patients With Cutaneous and Conjunctival Malignant MelanomaOphthalmic Plastic & Reconstructive Surgery, 2000
- Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscintigraphy and Gamma Probe–Guided Sentinel Lymph Node BiopsyJAMA Otolaryngology–Head & Neck Surgery, 2000
- Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloidSurgery, 1998
- Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphyThe American Journal of Surgery, 1995
- The Orderly Progression of Melanoma Nodal MetastasesAnnals of Surgery, 1994
- Experience with 998 cutaneous melanomas of the head and neck over 30 yearsThe American Journal of Surgery, 1991
- Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunkCancer, 1985